Publishing with BrainImmune

BrainImmune delivers up to date online information into the broad interdisciplinary area of neuroendocrine immunology and stress-immune interactions, and their impact on health and disease. See more info at our About’ page. BrainImmune’s aim is to narrow the information and conceptual gap at the interface of neurosciences and immunology.

WHY PUBLISH with us?
  1. Contribute to an internationally trusted Web-based, FREE-content project & resource in the vast interdisciplinary area of neuroendocrine-immunology and stress-immune interactions.
  2. Join our global community with over 150 contributors, from more than 25 countries worldwide, concerned with advancing the health and wellbeing of people worldwide.
  3. Exposure on the Web:
    a) Hardcopy textbooks have usually limited edition. In contrast, texts on the Internet have at least ten times as many readers as hardcopy books only, and Internet Websites are more advanced and offer more frequent updates.
    b) The Internet opens up unlimited possibilities of increasing the exposure of authors’ ideas and concepts directly online – it offers an opportunity to diversify and broaden the authors’ audience, beyond the relatively limited perimeter of the hardcopy journals or their online versions.
    c) A free-accessible online article offers a unique educational tool for students and trainees worldwide, or a valuable concise opinion for an expert who is not familiar with author’s area of expertise.
WHAT DO WE publish?

BrainImmune publishes short but comprehensive online articles written by experts in the field whose research has had a major influence on the development of the topic reviewed (see more at our ‘Authors Info’ page).

We publish the following article types: Short Reviews & Overviews – see an example; ‘Evolving Concepts’ articles – an example; Editorials and Opinion articles – an example; Commentaries – an example; History Overviews & short ‘Feature & Faces’ stories – example 1, example 2; ‘What’s Hot’ & Blogs’ style short news – example 1, example 2; News Reports – an example

OPEN access

BrainImmune is in full compliance with the latest open access mandates. Copyright of the articles are retained by the authors. Articles are licensed under the Creative Commons Attribution License. Thus, authors’ articles are freely available online, freely redistributed and reused, without restriction, as long as the original work is correctly cited.

ARTICLE Promotion

Your articles are widely promoted through email alerts, and via our Social Media channels on Twitter, LinkedIn, Pinterest and YouTube.

WE ARE INTERESTED in the following topics:
  1. Fundamental & clinical aspects of brain-immune interactions, i.e., neuroendocrine immunology and stress-immune interactions, and their impact on health and disease.
  2. We are exceptionally interested in novel evolving concepts & advanced conceptual frameworks in the vast interdisciplinary area of neuroendocrine immunology.
  3. Stress-immune interactions and the effect of stress hormones on immunity, and relevance to human diseases.
  4. News reports on your recent research progress and discoveries, and on the latest developments in neuroendocrine-immunology & stress-immunity research.
AND SPECIFICALLY in the following topics:
  1. The brain’s reward system and immunity.
  2. Brain’s glymphatic & drainage system and dementia | Alzheimer’s, see Reason #1 and Reason #2.
  3. Stress, anxiety and dementia and Alzheimer’s see Reason #1 and Reason #2
  4. Sensory nerves and immunity | inflammation, see Reason #1 and Reason #2.
  5. Oxytocin and immunity | stress | behaviour, see Reason #1 and Reason #2.
  6. Neuroendocrine immunology and stress-immune interactions of COVID-19, see Reason #1 and Reason #2.
  7. IL-17 and IL-23/IL-17 axis and any aspect of neuroendocrine immunology and stress-immune interactions, see Reason #1 and Reason #2.
  8. Stress, hormonal-immune interactions and reproduction & infertility, see Reason #1 and Reason #2.
  9. Stress and neuroendocrine immunology of human diseases including: infections, allergy/asthma; autoimmune and rheumatic diseases; atherosclerosis and cardiovascular diseases; stress and cancer; autonomic nerves and cancer; stress-induced T-helper 2 shift and cancer; catecholamines and melanoma, stress and breast cancer, stress and leukemia, beta blockers potential in cancer, fibromyalgia; CFS, major depression, Parkinson’s disease.

Ideally you hold an MD, PhD, DO, DC, DVM or PharmD, with a demonstrated record of publishing research. Clinicians without research experience may have publishing experience, including book/book chapters writing or editing.


Please contact the editor of BrainImmune at